Caladrius Chief Executive Officer, Dr. David Mazzo, discusses the Company’s cell therapy development and CDMO capabilities with Stock News Now’s Shelly Kraft at the Aegis 2016 Growth Conference in Las Vegas.

Click here to watch the interview.